emetine has been researched along with Idiopathic Inflammatory Myopathies in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
COVO, Y; DEVRIES, A; GALDETTI, M; PINHAS, Y | 1 |
Coltman, CA; Panettiere, F | 1 |
2 other study(ies) available for emetine and Idiopathic Inflammatory Myopathies
Article | Year |
---|---|
[MYOSITIS AND PARACENTRAL SCOTOMA DUE TO EMETINE AND ARALEN THERAPIES].
Topics: Chloroquine; Emetine; Myositis; Scotoma; Toxicology | 1963 |
Experience with emetine hydrochloride (NSC 33669) as an antitumor agent.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Colonic Neoplasms; Diarrhea; Electrocardiography; Emetine; Female; Humans; Injections, Intravenous; Laryngeal Neoplasms; Leukemia, Lymphoid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma; Myositis; Nausea; Tachycardia; Thyroid Neoplasms; Tracheal Neoplasms; Urinary Bladder Neoplasms | 1971 |